Aims Medication non‐adherence is frequent and is associated with high morbidity and
mortality in patients with chronic heart failure (CHF). We investigated whether an …

Abstract Background Mineralocorticoid receptor antagonists (MRAs) were shown to delay
chronic kidney disease (CKD) progression in patients with hypertension and/or heart failure …

Renin–angiotensin–aldosterone system (RAAS) inhibitors are the key medications for
patients with heart failure and chronic kidney disease. Multiple randomized controlled trials …

Background: Heart failure (HF) is a highly prevalent syndrome in elderly subjects. Currently,
multiple drugs have shown clinical benefits in patients with HF and reduced ejection fraction …

Background: Chronic kidney disease (CKD) is a major health issue and cardiovascular risk
factor. Validity assessment of administrative data for the detection of CKD in research for …

Purpose Despite CKD is common among older patients, and although factors associated
with CKD progression have been explored over decades, little is known about the decline of …

Heart failure (HF) is a common condition and one of the main morbidity and mortality factors
in elderly patients. The incidence of HF progressively increases with age, reaching> 10% in …

OBJECTIVE To assess the role of beta-blockers (BB) in patients with chronic kidney disease
(CKD) aged≥ 75 years. METHODS AND RESULTS From January 2008 to July 2014, we …

目的研究沙库巴曲缬沙坦钠联合酒石酸美托洛尔对老年慢性心力衰竭患者心脏重构及心功能的
影响. 方法选取老年慢性心力衰竭患者146 例于南阳医学高等专科学校第一附属医院2019 年12 …

Controversy over renin–angiotensin–aldosterone system (RAAS) inhibitors treatment in
nephrology and cardiovascular diseases Page 1 45 www.ah.viamedica.pl Review Address …